实时全球研报
AUSTRALIA FIRST TO MARKET
研报英文原文证据摘录
AUSTRALIA FIRST TO MARKET
Asia Pacific Equity Research
Australia First to Market 04 August 2026
Top Stories
Fortescue (Lyndon Fagan) (FMG AU, OW)
4Q26 results: record FY26 shipments overshadowed by cost inflation and weak Iron Bridge outlook;
retain OW
Key takeaways: 1) Q4 hematite shipments were ahead of JPMe, while unit costs were a touch lower; despite a weaker than
expected achieved price, the company finished the period in a better than expected net debt position of just $0.8bn, 2) Iron
Bridge continues to struggle - a $750m impairment has been recorded, FY27 attributable costs are ~$900m or around $100/t,
no value in use premium is being achieved, and medium-term cost guidance / nameplate capacity looks optimistic - we no
longer have a positive NPV for the asset and expect a FY27 loss of $150m (the asset now lacks relevance), 3) FY27 hematite
C1 guidance of ~$21/t is up ~9% YoY, and although we had this captured in our numbers; it was about $1/t higher than cons;
FY27 capex guidance is also higher than the street at $3.8-4.8bn (but in line with JPMe). The significant cost pressures created
from diesel, explosives, and higher AUD are being felt in what we regard as a very well run business - it provides a read
through into what we could expect from BHP / MIN iron ore cost guidance in August. Our FY27 earnings are down just 1%, but
our NPV falls 7% after wiping out Iron Bridge, and factoring in higher capex for hematite. The stock screens cheap on a P/NPV
of 0.82x, but our 1yr fwd EV/EBITDA is closer to ~6x and there is limited FCF yield. We expect near-term share price pressure
on weak sentiment, but can see the stock trading higher as iron ore bounces out of the cost curve through the balance of the
year. Maintain OW with $23 PT (from $24ps).
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器